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Abstract
Purpose Retinopathy of prematurity
(ROP) is a disorder of developing retinal
blood vessels in preterm infants.
The purpose of this nested study was to
investigate the effects of higher (91–95%)
and lower (85–89%) oxygen saturation
(SpO2) targeting on retinal blood vessel
growth in preterm infants.
Methods Retinal blood vessel growth in
the higher (91–95%) and lower (85–89%)
oxygen saturation (SpO2) targeting groups
was compared. Suitable RetCam (Clarity,
Pleasanton, CA, USA) images collected in
the BOOST-II UK trial were used. The
distances between the centre of the optic
disc and the ROP ridge in the temporal and
nasal retina were measured in pixel units.
Results Images from 38 infants were
studied, 20 from the higher SpO2 target
group and 18 from the lower SpO2 target
group. On average, temporal blood vessels
extended further from the optic disc than
nasal blood vessels, mean (standard deviation
(SD)) 463.39 (55.05) pixels compared with
360.13 (44.47) pixels, respectively, Po0.0001.
Temporal blood vessels extended less far
from the optic disc in the higher SpO2 target
group than in the lower SpO2 target group:
mean (SD) 449.83 (56.16) pixels compared
with 480.02 (49.94), respectively, P= 0.055.
Nasal retinal blood vessel measurements
were broadly similar in the higher and
lower SpO2 target groups; mean (SD) 353.96
(41.95) compared with 370.00 (48.82) pixels,
respectively, P= 0.38.
Conclusions Relatively high oxygen
saturation targeting (91–95%) was associated
with a trend (P= 0.055) towards reduced
retinal blood vessel growth in this study of
preterm infants.
Eye (2016) 30, 577–581; doi:10.1038/eye.2015.280;
published online 22 January 2016
Introduction
Retinopathy of prematurity (ROP) is a disorder
of developing retinal blood vessels in preterm
infants. Normal vascular development starts at
the optic nerve and radiates peripherally,1 by
vasculogenesis and vascular endothelial growth
factor (VEGF)-mediated angiogenesis processes.2
Clinical and animal studies have suggested
that ROP occurs in two phases.3 Phase 1 is
associated with the higher blood and tissue
oxygen levels in the preterm infant than occur
in utero. This follows preterm birth into environ-
mental air, exacerbated by supplemental oxygen.
Increased oxygen levels are thought to result
in downregulation of VEGF, with delayed
vascularisation. However, in vivo human studies
have not yet been conducted. Phase 2 consists
of a vasoproliferative response following reduced
blood vessel development in phase 1. The
attenuated vasculature can no longer supply
sufﬁcient oxygen and nutrients to the growing
avascular peripheral retina, and this results in
greatly increased expression of VEGF. In addition
to oxygen-mediated effects, phase 1 is associated
with low levels of circulating IGF1 and phase 2
with more normal levels of IGF1.4,5 IGF1 is
required for VEGF-mediated angiogenesis.6,7
Risk factors for ROP may be divided into
prenatal and postnatal factors. Prenatal
factors affect the degree of retinal blood vessel
development present at the time of preterm
birth. The incidence of ROP is higher in
infants of lower gestational age and birth
weight, and in infants small for gestational age.8
Postnatal factors reﬂect divergence from in utero
conditions.9 Supplemental oxygen represents the
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best understood postnatal risk factor for ROP.
Randomised controlled trials have shown that restricted
oxygen therapy results in a lower incidence of severe
ROP, but mortality is increased.3,10–12
The aim of this nested study was to investigate the
effects of higher (91–95%) and lower (85–89%) oxygen
saturation (SpO2) targeting on retinal blood vessel
growth in preterm infants. Data from infants included
in the BOOST-II UK (Beneﬁts of Oxygen Saturation
Targeting) randomised controlled trial11 were analysed.
Our hypothesis was that exposure to higher SpO2
targeting inhibits blood vessel growth compared with
lower SpO2 targeting.
Subjects and methods
Analyses were based on eye examination data obtained
as part of the BOOST-II UK trial.11 973 infants aged less
than 28 weeks’ gestation at birth were enrolled. In 12
of the study centres, retinal images were obtained by
a consultant paediatric ophthalmologist using a contact
wideﬁeld digital fundus camera (RetCam, Clarity
systems, Pleasanton, CA, USA) at the time of ROP
screening examinations. The images were uploaded
onto a secure study server for reading and analysis.
Good quality images that included adequate views of
the optic disc, the temporal retinal blood vessel arcades,
and a temporal or nasal ROP demarcation line or ridge
were selected. Our analysis was restricted to images
obtained from screening examinations on infants less than
36 weeks (252 days) postmenstrual age (PMA) at the time
of examination, as the trial intervention ﬁnished at this
age. All measurements were performed by observers who
were masked to the trial group allocation. Measurements
were made using bespoke digital imaging software
(http://www.VisionResearch.org) that allowed accurate
linear measurements to be made (Figure 1). The angle of
measurement from the optic disc was that judged to fall
on a line midway between the temporal vascular arcades.
This applied to both temporal and nasal measurements.
Measurement was then made between the centre of the
optic disc and the point at the outer margin of the ROP
ridge. Measurements were expressed in camera pixel
units. Each measurement was made independently on
three occasions by two observers (RBRM and BWF) and
the six results were averaged.
The set of images from each infant examination was
incomplete in many cases. Images of adequate quality for
measurement from both the temporal and nasal retina of
both eyes were only available for two examinations. For
each infant examination, a temporal retinal measurement
from one eye and a nasal retinal measurement from one
eye were analysed, where available. When a temporal
or a nasal measurement was available from both eyes,
one eye was randomly selected.
Intra-observer measurement variation was assessed by
obtaining the difference between the highest and lowest
measurement of the three measurements performed by
each observer, and inter-observer measurement variation
was assessed by obtaining the difference between the
averaged measurements obtained by each observer,
for each image.
Statistical analysis
Demographic and clinical data were summarised
with counts for categorical variables, means (standard
deviations) for normally distributed continuous variables
and medians (with simple ranges) for other continuous
variables. Comparative statistical analysis entailed
calculating the mean difference (plus 95% CI) for normally
distributed continuous outcomes. Agreement between
the two observers was assessed using Bland–Altman
plots.13 Analysis was ﬁrst performed using all available
examinations. However, as there were multiple
examinations for some individuals, and these were
technically statistically not independent, a further analysis
was performed, restricted to one examination for each
infant. All analyses were performed using GraphPad
Prism 6 software (GraphPad, La Jolla, CA, USA).
Ethics approval statement
This study was a nested study within the BOOST-II UK
trial, approved by the Trent Research Ethics Committee,
reference 06/MRE04/91.
Figure 1 Measurement of the distance from the centre of the
optic disc to the outer edge of the ROP ridge, along an axis
bisecting the temporal blood vessel arcades.
Retinal vessel growth is retarded by high oxygen saturation
RBR Moreton et al
578
Eye
Results
At the close of the BOOST-II UK study data collection, the
retinal image database contained 2,022 images taken
during 432 eye examinations, from 134 infants. Ninety-
nine images taken during 57 screening examinations from
38 infants were of sufﬁcient quality to allow retinal blood
vessel measurements to be obtained. Sixty-ﬁve were
images of the temporal retina and thirty-four of the nasal
retina. The median gestational age of the 38 infants
studied was 25 weeks+0 days (range 22 weeks+6 days to
27 weeks+56 days), and the median birth weight was
740 g (range 450–1,200 g). Twenty-one infants were
female. Maternal ethnicity was white in all cases. Eighteen
infants were from the low oxygen saturation targeting
group, and twenty were from the high oxygen saturation
targeting group.
Agreement between the two observers is shown in
Figure 2. The 95% conﬁdence intervals were − 9.43 to
+12.04 pixels and the measurement bias between the two
observers was a mean (SD) of 1.31 (5.48) pixels. The
repeatability coefﬁcient for measurements was 7.63 pixels
for BWF and 9.31 pixels for RBRM.
On average, temporal blood vessels extended further
from the optic disc than nasal blood vessels, mean (SD)
463.39 (55.05) pixels compared with 360.13 (44.47) pixels,
Po0.0001 (Figure 3). The timing of these examinations
was 242.33 (7.51) days PMA for the temporal group and
239.35 (9.23) days PMA for the nasal group (P= 0.20).
Temporal vessels extended less far from the optic disc in
the higher SpO2 target group than the lower SpO2 target
group, mean (SD) 449.83 (56.16) pixels compared with
480.02 (49.94) pixels, respectively, P= 0.055, (Figure 4).
There was no evidence of a difference between the two
groups for nasal retinal blood vessel growth, mean (SD)
353.96 (41.95) pixels, compared with 370.00 (48.82) pixels,
respectively, P= 0.38.
In 26 infants, measurements were available from a
single examination. For eight infants, measurements were
available from two examinations, in two infants from
three examinations, in one infant from four examinations
and in one infant from ﬁve examinations. Further analysis
was performed by selecting one examination from each
infant, to produce ‘per patient’ analysis rather than ‘per
examination’ analysis. The median PMA at the time of
examination for all study examinations was 34 weeks
+1 day. In order to analyse a single set of measurements
from each infant, the examination closest to this time was
selected for each infant. Measurement of one temporal
and one nasal image per infant showed that temporal
blood vessels grew further from the optic disc than nasal
blood vessels; mean (SD) 461.08 (59.55) pixels compared
with 355.47 (42.83) pixels, Po0.0001. Temporal vessels
extended less far in the higher SpO2 target group than in
the lower SpO2 target group, mean (SD) 453.73 (64.72)
pixels compared with 469.91 (53.54) pixels, however,
there was no statistical evidence of a difference (P= 0.45).
Nasal vessels extended mean (SD) 351.25 (45.98) pixels in
the higher SpO2 target group, compared with 361.66
(39.81) pixels in the lower SpO2 target group, P= 0.61.
Figure 2 Bland–Altman plot of pixel measurements made by
the two observers. Dashed lines show 95% conﬁdence intervals.
Figure 3 Growth of retinal blood vessels of the temporal and
nasal retina expressed as camera pixels from the centre of the
optic disc to the intersection with the ROP ridge. Box and
whiskers plot.
Figure 4 Growth of retinal blood vessels of the temporal retina
in the low and high SpO2 targeting groups expressed as camera
pixels from the centre of the optic disc to the intersection with the
ROP ridge. Box and whiskers plot.
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Discussion
In this study, we found that retinal blood vessels
extended further in the temporal retina than the nasal
retina. This is consistent with a previous study.14 ROP
frequently develops ﬁrst in the nasal retina in the most
immature infants.15 The mean PMA at which nasal
measurements were made was 3 days earlier than for
temporal measurements. Images were selected, based on
the presence of an ROP ridge. It is conceivable that
development of an ROP ridge causes reduced forward
growth of retinal blood vessels. As this occurs earlier in
the nasal retina than in the temporal retina, the effect may
contribute to the nasal/temporal asymmetry observed.
However, our data were of insufﬁcient quality or quantity
to analyse these possible effects, which therefore remain
speculative.
Temporal retinal vessels extended less distance from
the optic disc in the higher SpO2 (91–95%) target group
than in the lower SpO2 (85–89%) target group. Although
the BOOST-II UK trial measured the effects of SpO2
targeting, the actual oxygen saturations achieved were
conﬁrmed to be different in the two groups.11 Relative
hyperoxia during the early postnatal period in preterm
infants is thought to reduce normal ‘physiological
hypoxia’ control of retinal blood vessel angiogenesis. We
found a trend towards an association between oxygen
saturation targeting and retinal blood vessel growth.
However, with a P value of 0.55, the association was not
robust. We have not demonstrated causation. Models of
ROP have shown impaired blood vessel growth in
animals raised in a hyperoxic environment when
compared with those raised in room air.16–19 A number of
clinical studies have shown abnormal retinal blood vessel
growth in infants treated with supplemental oxygen, but
have not quantiﬁed the effect.3
Our measurements beneﬁted from the use of two
observers with a high level of concordance. However, it is
likely that error occurred due to limitations in the extent
to which each observer was able to accurately and
consistently position the screen cursor at reference points
determined using a subjectively judged angle.
Measurement of the extent of temporal vascularisation is
made more difﬁcult by the presence of a temporal ‘notch’
in some eyes. We chose an anatomically consistent
reference point in relation to the temporal vessel arcades
in order to reduce variation based on asymmetry of the
extent of temporal retina vascularisation. An alternative
approach would have been to make measurements at
multiple points along the ROP ridge, as was done in the
study by Gallagher et al.14
Comparisons of measurements were based on the
assumption that optical magniﬁcation was identical in all
eyes, which although likely,20 may not have been the case.
A further source of error may have resulted from
measurement of two-dimensional images of three-
dimensional curved structures. Linear magniﬁcation of
radially orientated lines is greatest in the centre of each
image and much smaller near their edge. Future work
should address this issue through mathematical
modelling of the coordinates of each reference point
relative to the centre of the image.
Despite the methodological limitations of this study,
the results lend some support to the hypothesis that
higher oxygen levels inhibit blood vessel growth in the
developing retina, compared with lower oxygen levels.
The limited number of observations available to us
restricted the statistical conﬁdence of this result. Although
we found a trend, the association remains unproven. We
have not demonstrated causation. Our data are unique,
and no further oxygen trials in preterm infants are
planned. Should further clinical oxygen trials in preterm
infants be conducted, an attempt should be made to
replicate and extend our ﬁndings. In addition, further
work is required to better deﬁne how retinal vessel
development sensitivity to oxygen saturation varies
with PMA.
Summary
What was known before
K Laboratory models of retinopathy of prematurity have
shown impaired retinal blood vessel growth in hyperoxic
conditions. Previous clinical studies have shown a
qualitative impairment of retinal blood vessel
development in association with high saturation oxygen
therapy.
What this study adds
K We have shown a quantitative trend (P= 0.055) towards
an association between high oxygen saturation targeting
therapy and reduced retinal blood vessel growth.
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